BrainsWay Raises 2026 Guidance After 35% Revenue Growth

Earnings
โดย The Motley Fool·US·Read original
Summary · why it matters

BrainsWay reported second quarter 2026 revenue of $17.1 million, up 35% from $12.6 million a year earlier, and raised its full-year guidance to between $68 million and $70 million. The company shipped 125 Deep TMS systems during the quarter, bringing its installed base to approximately 1,950 systems, while remaining performance obligations grew 30% to $80.4 million. Operating income increased over 300% to $2.4 million, and adjusted EBITDA rose 141% to $3.5 million, marking the 12th consecutive quarter of positive adjusted EBITDA. BrainsWay also announced strategic minority investments in HopeMark Health, Radial Health, and Sound Minds Behavioral, and noted that its SWIFT accelerated Deep TMS protocol now has approximately 57 million covered lives in the U.S.

Impact on stocks 1

Health Care▲ · 1 stocks

Off-coverage companies 3

HopeMark HealthPrivate▲ Positive
Capitalrelevance

BrainsWay made a strategic minority investment in HopeMark Health, indicating a positive financial backing.

Radial HealthPrivate▲ Positive
Capitalrelevance

BrainsWay made a strategic minority investment in Radial Health, indicating a positive financial backing.

Sound Minds BehavioralPrivate▲ Positive
Capitalrelevance

BrainsWay made a strategic minority investment in Sound Minds Behavioral, indicating a positive financial backing.

© 2026 MarketDXNews